Disease-relevant autoantibodies in first episode schizophrenia.

Disease-relevant autoantibodies in first episode schizophrenia.

Detalhes bibliográficos
Principais autores:	Zandi, MS, Irani, SR, Lang, B, Waters, P, Jones, P, McKenna, P, Coles, A, Vincent, A, Lennox, B
Formato:	Journal article
Idioma:	English
Publicado em:	2011

Registros relacionados

ANTI-GAD65, NMDAR AND VGKC ANTIBODIES DETECTED IN FIRST EPISODE PSYCHOSIS
por: Lennox, B, et al.
Publicado em: (2009)

Screening for encephalitis-causing autoantibodies in serum and CSF of first-episode psychosis patients and controls
por: Theorell, J, et al.
Publicado em: (2020)

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
por: Theorell, J, et al.
Publicado em: (2021)

Autoantibodies associated with diseases of the CNS: new developments and future challenges.
por: Vincent, A, et al.
Publicado em: (2011)

Potentially pathogenic autoantibodies associated with epilepsy and encephalitis in children and adults.
por: Vincent, A, et al.
Publicado em: (2011)

Decision making deficits in patients with first-episode and chronic schizophrenia.
por: Hutton, S, et al.
Publicado em: (2002)

The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins.
por: Vincent, A, et al.
Publicado em: (2010)

Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.
por: Irani, SR, et al.
Publicado em: (2014)

Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
por: Michael, S, et al.
Publicado em: (2020)

Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis
por: Pollak, T, et al.
Publicado em: (2018)

Encephalitis and schizophrenia: a matter of words reply
por: Lennox, B, et al.
Publicado em: (2012)

Absence of neuronal autoantibodies in neuropsychiatric systemic lupus erythematosus
por: Varley, JA, et al.
Publicado em: (2020)

Antibody-mediated encephalitis: a treatable cause of schizophrenia.
por: Lennox, B, et al.
Publicado em: (2012)

Linear- versus conformational-protein directed autoantibodies in neuropsychiatric systemic lupus erythematosis
por: Varley, J, et al.
Publicado em: (2017)

CXCL13 levels in LGI1-and CASPR2-autoantibody syndromes
por: Michael, S, et al.
Publicado em: (2019)

Autoantibody testing in encephalopathies.
por: Lee, R, et al.
Publicado em: (2012)

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
por: Jakob Theorell, et al.
Publicado em: (2021-11-01)

CXCL13 levels and autoantibody epitope specificities in LGI1-autoantibody syndromes
por: Michael, S, et al.
Publicado em: (2019)

Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis
por: Thomas A. Pollak, et al.
Publicado em: (2018-07-01)

Republished review: Autoantibody testing in encephalopathies.
por: Lee, R, et al.
Publicado em: (2012)

Autoantibody-mediated disorders of the central nervous system.
por: Irani, S, et al.
Publicado em: (2008)

The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis
por: Ramanathan, S, et al.
Publicado em: (2019)

Autoantibodies in epilepsy
por: Lang, B, et al.
Publicado em: (2007)

Autoantibody-mediated neurological diseases
por: Varley, JA, et al.
Publicado em: (2020)

Diagnostic use of autoantibodies in myasthenia gravis.
por: Leite, M, et al.
Publicado em: (2010)

Pathogenicity of autoantibodies in stiff-person syndrome
por: Chang, T, et al.
Publicado em: (2008)

The experience of using aripiprazole in a serivice for first episode psychoisis
por: Shoesmith, W, et al.
Publicado em: (2006)

MORVAN'S SYNDROME: CLINICAL AND SEROLOGICAL FINDINGS IN 27 CASES
por: Irani, SR, et al.
Publicado em: (2011)

First episode schizophrenia
por: Nadira Khamker
Publicado em: (2015-09-01)

The immunology underlying CNS autoantibody diseases
por: Cleaver, J, et al.
Publicado em: (2024)

Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy.
por: Brenner, T, et al.
Publicado em: (2013)

Real-world prevalence of autoantibodies in epilepsy
por: McGinty, RN, et al.
Publicado em: (2020)

Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.
por: Varley, J, et al.
Publicado em: (2014)

Controversies in the detection of neural autoantibodies
por: Philippa Pettingill, et al.
Publicado em: (2016-09-01)

A novel antigenic target in Morvan's syndrome
por: Irani, SR, et al.
Publicado em: (2008)

Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
por: McGinty, R, et al.
Publicado em: (2020)

Autoantibodies to ion channels at the neuromuscular junction.
por: Lang, B, et al.
Publicado em: (2003)

The functional anatomy of auditory hallucinations in schizophrenia.
por: Lennox, B, et al.
Publicado em: (2000)

Autoantibodies and the nervous system
por: Vincent, A, et al.
Publicado em: (2008)

Serum Autoantibodies: From Identification to Clinical Relevance
por: Pietro Invernizzi, et al.
Publicado em: (2013-01-01)